The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.

By Marno C. Ryan, C. Itsiopoulos, T. Thodis, G. Ward, N. Trost, Sophie C. Hofferberth, K. O'dea, P. Desmond, N. Johnson, Andrew M Wilson. Journal of Hepatology, 2013

716 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology

View Paper: https://www.semanticscholar.org/paper/54aa34c5fe9e176d8f97be42e8aa9e01bc99ed9b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. M. Pinzani
2. E. Tsochatzis
3. E. Buzzetti

In Epidemiology

1. Shira Zelber-Sagi
2. M. Pinzani
3. E. Tsochatzis
4. E. Buzzetti

Citations in the corpus

• The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). (2016, background): “randomized trial, the Mediterranean diet improved steatosis and insulin resistance even without weight loss in patients with insulin resistance and NAFLD [129].”
• Treatment of NAFLD with diet, physical activity and exercise. (2017, background): “Liver fat content decreased more in the MUFA or the Mediterranean diet (about 35%) than in the low fat high carbohydrate diet (about 5%), despite a stable weight in both groups.(43,44) Importantly, the Mediterranean diet is also characterised by reduced carbohydrate intake (40% of the calories vs.”